Labuxtinib

CAS No. 1426449-01-5

Labuxtinib( —— )

Catalog No. M37250 CAS No. 1426449-01-5

Labutinib is a selective inhibitor of the c-kit tyrosine kinase .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 216 Get Quote
5MG 337 Get Quote
10MG 541 Get Quote
25MG 1040 Get Quote
50MG 1500 Get Quote
100MG 1971 Get Quote
200MG 2655 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Labuxtinib
  • Note
    Research use only, not for human use.
  • Brief Description
    Labutinib is a selective inhibitor of the c-kit tyrosine kinase .
  • Description
    Labuxtinib is c-kit tyrosine kinase inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR | c-Kit
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1426449-01-5
  • Formula Weight
    377.37
  • Molecular Formula
    C20H16FN5O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (331.24 mM; Ultrasonic )
  • SMILES
    C(NC1=CC(=CC=C1C)C=2N=C(ON2)[C@@H]3[C@@H](F)C3)(=O)C=4N5C(=NC4)C=CC=C5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yeh Vince, et al. Imidazopyridine compounds and compositions as c-kit kinase inhibitors and their preparation. World Intellectual Property Organization, WO2013033070 A1. 2013-03-07.
molnova catalog
related products
  • Mobocertinib

    Mobocertinib is a potent ?inhibitor of epidermal growth factor receptor (EGFR) and an antineoplastic agent.

  • Tyrphostin AG 1296

    Tyrphostin AG 1296 is an inhibitor of PDGFR with IC50 of 0.3-0.5 μM, no activity to EGFR.

  • AG18

    AG-18(RG-50810; Tyrphostin A23) inhibits EGFR with IC50 of 35 μM.